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Abstract 
In this case study, we aimed at evaluating the suitability of genome-scale metabolic models to identify molecular targets that can 
potentially enhance antimicrobial effects of chemical preservatives against P. aeruginosa, while minimizing biofilm formation. 
For the case study, isothiazolinones were selected as a group of microbicides where their mechanism of action is well described in 
scientific literature. Target identification was carried out in several steps. First, we developed a computational model of P. 
aeruginosa metabolism under action of isothiazolinones. Action of sub-inhibitory concentrations of isothiazolinones was simulated 
based on extensive information on their mechanisms of action. Then, simulations of single and double gene deletion(s) were 
performed in silico to identify genes or combinations of genes that could be targeted to induce further reduction of bacterial growth 
rate. Finally, we assessed whether total or partial inhibition of these genes might activate biofilm formation. 
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1. Introduction 
Genome-scale metabolic models (GSMMs) provide a biologically meaningful mechanistic basis for elucidating the 
genotype-phenotype relationship. GSMMs contain curated and systematized information about known metabolites 
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and metabolic reactions of a given type of cell, based on its annotated genome, and on available data/information in 
experimental literature. The ability of GSMMs to predict effects of gene knockouts has enabled their application in 
metabolic engineering studies as well in the discovery of drug targets. However, little or no application of GSMMs 
has been reported to support the design of microbial control strategies based on chemical preservatives in consumer 
products. To evaluate this potential application, we have chosen isothiazolinones as a group of antimicrobial 
compounds with known mechanism of action reported in experimental literature. The mechanism by which 
isothiazolinones inhibit Gram-negative bacteria has been linked with disruption of the metabolic pathways involved 
in dehydrogenase, inhibition of oxygen consumption and energy generation (Williams, 2007). The aim of this work 
is to identify molecular targets that could enhance action of isothiazolinones against P. aeruginosa while minimizing 
biofilm formation. 
A number of studies have shown that GSMMs could be used to accurately predict molecular targets essential for 
growth (e.g. Lee et al., 2009). The method consists in simulating gene(s) deletion using Flux Balance Analysis (FBA) 
and identifying a gene (or a group of genes) that could be targeted to prevent growth of the pathogen. These targets 
can then be mapped to existing compounds following e.g. the framework proposed by Chavali et al. (2012). More 
recently, GSMMs have also been used to predict metabolic rearrangements induced by gene inhibition. Of interest for 
this work, Xu et al. (2013) developed a framework to predict if exposure to low concentrations of antimicrobials can 
induce rearrangements in the metabolism of P. aeruginosa that activate biofilm pathways. In this work, target 
identification was carried out in several steps. First, we developed a computational model of P. aeruginosa metabolism 
under action of isothiazolinones. Then, simulations of gene deletions were performed in silico to identify genes and 
combinations of genes that could be targeted to potentiate the effects of isothiazolinones. Finally, we assessed whether 
partial inhibition of these genes might activate biofilm formation. 
2. Materials and Methods 
2.1. Computational model of P. aeruginosa in presence of sub-inhibitory concentrations of isothiazolinones 
Metabolism of P. aeruginosa was modelled based the iMO1086 reconstruction (Oberhardt et al., 2011). NADH 
dehydrogenases and reactions associated with PA1124 and PA3043 (two genes associated with biofilm formation) 
were implemented as in the previous iMO1056 reconstruction (Oberhardt et al., 2008). For the purpose of this case 
study, uptakes of nutrients were defined to mimic water environments. In particular, carbon sources were assumed to 
be carboxylic acids (succinate, acetate, citrate and pyruvate). In absence of relevant gene expression data in public 
databases, effects of isothiazolinones on the cell metabolism of P. aeruginosa were simulated by reducing the bounds 
of fluxes in reactions known as being affected by isothiazolinones (pyruvate, lactate, succinate, oxogluterate and 
NADH dehydrogenases, ATP synthesis and aerobic respiration). First, the solution space corresponding to the 
maximum growth rate in absence of isothiazolones was sampled using the Artificial Centre Hit and Run (ACHR) 
sampling included in the COBRA Toolbox. For each metabolic reaction, it results in N sampled flux values which 
were analyzed to quantify the mean value and the probability density function of fluxes. Then, action of sub-inhibitory 
concentrations of isothiazolinones was mimicked by setting the upper bound of fluxes in reactions affected by these 
antimicrobials to 75% of the mean of the density function. For reversible reactions, the lower bound of fluxes were 
set to –75% of their mean value. Application of these constraints induced a reduction of 80% in the predicted growth 
rate. 
2.2. Identification of targets that may enhance effects of isothiazolinones 
Perturbation analysis was performed using FBA and the COBRA Toolbox on the metabolic model of P. aeruginosa 
in presence of isothiazolinones. We used maximization of biomass generation as an objective function for FBA, as it 
has proven to be effective in predicting redistribution of metabolic fluxes (Edwards et al., 2001; Brynildsen et al., 
2013). Perturbation analysis was performed by simulating single and double gene deletion with FBA. For each single 
deletion, it was assessed if complete inhibition of gene(s) function results in a further reduction of the bacterial growth. 
Single and double genes deletions that result in further growth rate reduction are identified as potential targets and 
selected for further analysis. 
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2.3. Investigation of biofilm formation capability 
Potential targets were mapped to sets of genes identified reported as being positively or negatively associated with 
biofilm formation by Müsken et al. (2010). Targets were further investigated using the framework of Xu et al. (2013). 
A set of biofilm-associated metabolic reactions were obtained by mapping genes identified as involved in biofilm 
formation onto the metabolic model. For each target inhibition, its function was simulated by reducing the bounds of 
the reactions associated with the target. ACHR sampling was performed to study the distribution of fluxes throughout 
the metabolic network. The fluxes of the biofilm-associated reactions were used as soft sensors to predict the ability 
of a cell with genes of interest inhibited to form biofilm as described by Xu et al. (2013). The trend to form biofilms 
for each mutant of gene(s) identified was quantified by comparing the distribution of fluxes of each biofilm-associated 
reaction to its counterpart obtained for the “wild-type” strain. The rationale for the use of biofilm-associated reactions 
is that a large enhancement of fluxes through these reactions reflects a large potential for the cell to form biofilms. A 
Kolmogorov-Smirnow test approach was used to identify significant differences in the flux distributions. 
3. Results  
3.1. Identification of targets that may enhance effects of isothiazolinones 
The single gene deletion analysis did not allow to identify targets that can specially potentiate effects of 
isothiazolinones (bacterial inhibition is predicted either in presence or in absence of isothiazolinones). However, 
systematic double gene deletions allowed the identification of combinations of genes that are not essential in absence 
of preservatives but could be targeted to induce further inhibition in presence of isothiazolinones. Analysis shows than 
achieving complete inhibition of the succinate dehydrogenase (already targeted to by the isothiazolinones) would lead 
to 864 possible co-targets to achieve complete inhibition. The analysis also allowed to identify 878 gene combinations 
that are not targeted by isothiazolinones but whose deletions are predicted to achieve complete inhibition or induce 
further decrease of the bacterial growth rate. Note that deletion of these gene combinations are predicted to cause little 
or no inhibition in absence of isothiazolinones. Table 1 shows the 20 potential target combinations which are predicted 
to induce at least a further 70% reduction of the growth rate. 
 
Table 1. Target combination which are predicted to induce a further reduction of bacterial growth rate >70% in presence of 
isothiazolinones. 
Main Gene (associated 
reactions)  
In combination with the following genes 
PA1982 (IR07019, 
IR02668, IR03599)  
PA0105 or  PA0106  or PA0107  or PA0108 or  PA0110 or PA0111 or PA0112 or PA0113 
or PA1252 or PA5436 or PA5437 
PA2366 (IR10013) PA0105 or PA0106 or PA0107 or PA0108 or PA0110 or PA0111 or PA0112 or PA0113 or 
PA3397 
 
3.2. Investigation of biofilm formation capability 
394 genes were reported as being positively associated with biofilm information by Müsken et al. (2010) and 79 
of these biofilm associated genes are included in the genome-scale metabolic model. 58 of these genes have no effect 
on the bacterial growth rate (both in presence and in absence of isothiazolinones). The 45 reactions associated with 
these 58 genes were considered as biofilm-associated reactions. 
Direct mapping of the potential targets from Table 1 with the biofilm-associated reactions showed that 17 
combinations contain at least one biofilm associated gene. They therefore appear as good candidates for enhancing 
action of the antimicrobials while minimizing biofilm formation. Application of the framework of Xu et al. (2013) 
showed that other remaining combinations do not lead to a significantly increased activity in biofilm-associated 
reactions. 
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4. Discussion  
Most of the methods described here have been developed in the context of clinical microbiology. However, this 
case study suggests that they may also be relevant for designing of antimicrobial preservation strategies in an industrial 
context. Incorporating specific information on mode of action of preservatives in the metabolic model made it possible 
to identify potential targets that would not have been detected otherwise. 
To simulate the action of isothiazolinones, we have applied a uniform reduction of the fluxes through targeted 
reactions to achieve an arbitrary 80% reduction of the growth rate. It is however unlikely that (i) all these reactions 
are affected to the same extent and (ii) that the antimicrobial action on the cell metabolism is limited to these few 
reactions. Transcriptomic and metabolomics profiles of P. aeruginosa in response to isothiazolinones would provide 
a more comprehensive information on action of these antimicrobials. It is also expected that mapping the gene 
expression data onto the GSMM (see e.g. Blazier et al., 2012 for a review of existing methods) would allow identifying 
new targets and increase accuracy of identification. In absence of gene expression data in literature, we have used 
available information on mode of action of isothiazolinones to simulate the action of these antimicrobials. 
In this case study, reduction of bacterial growth was considered as a strategy for potentiating the effects of 
isothiazolinones. As these antimicrobials are usually used at concentrations beyond MIC/MBC, other strategies such 
as targeting resistant pathways may be more relevant. As the mechanism by which isothiazolinones eventually kill 
bacterial cells has been linked to oxidative stress and ROS species, another possible strategy would be to identify gene 
knockouts that can increase endogenous ROS production (as described by Brynildsen et al., 2013). 
Validation of potential targets should focus on (i) mapping these targets to existing antimicrobials; (ii) testing the 
efficacy of these compounds to enhance bacterial inhibition (Chavali et al., 2012). The benefit that such systems levels 
methods can bring to the industry will also depend on our ability to map molecular targets to existing compounds (and 
therefore on our knowledge of mode of actions of antimicrobials). It will also depend on availability of GSMMs for 
environmental isolates. 
5. Conclusion 
This case study demonstrates the potential of genome-scale metabolic models to design novel antimicrobial 
strategies. Further work is needed to develop and/or adapt the most suitable modelling approaches and to understand 
how to apply them in an industrial context. 
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